Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label limited access protocol of posaconazole in invasive fungal infections
2005-003717-33Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of posaconazole in invasive mycoses, sponsored by Merck & Co. Started Jan 2007; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on 2005-003717-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003717-33.